February 9, 2022 Comments Off on New patent for Intra-cellular drug CAPLYTA Posted in: Patent Added Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. There are eleven patents protecting this drug. CAPLYTA drug price trends.…
The post New patent for Intra-cellular drug CAPLYTA appeared …
February 9, 2022 Comments Off on Which pharmaceutical companies have the most SPCs in Estonia? Posted in: Infographic This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Estonia. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
